𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients

✍ Scribed by Raphaël Maréchal; Jef De Schutter; Nathalie Nagy; Pieter Demetter; Arnaud Lemmers; Jacques Devière; Isabelle Salmon; Sabine Tejpar; Jean-Luc Van Laethem

Book ID
115010098
Publisher
BioMed Central
Year
2010
Tongue
English
Weight
970 KB
Volume
10
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluorouracil, Leucovorin, and Oxaliplati
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
✍ Bokemeyer, C.; Bondarenko, I.; Makhson, A.; Hartmann, J. T.; Aparicio, J.; de Br 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 201 KB

## Purpose This randomized study assessed whether the best overall response rate (ORR) of cetuximab combined with oxaliplatin, leucovorin, and fluorouracil (FOLFOX-4) was superior to that of FOLFOX-4 alone as first-line treatment for metastatic colorectal cancer. The influence of KRAS mutation sta